These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9420288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Murine leukemia virus long terminal repeat sequences can enhance gene activity in a cell-type-specific manner.
    Yoshimura FK, Davison B, Chaffin K.
    Mol Cell Biol; 1985 Oct; 5(10):2832-5. PubMed ID: 3016518
    [Abstract] [Full Text] [Related]

  • 5. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
    Ch'ang LY, Yang WK, Myer FE, Yang DM.
    J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA, Mullen CA, Morgan RA.
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [Abstract] [Full Text] [Related]

  • 9. Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences.
    Jäger U, Zhao Y, Porter CD.
    J Virol; 1999 Dec; 73(12):9702-9. PubMed ID: 10559279
    [Abstract] [Full Text] [Related]

  • 10. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A, Takimoto M, Adachi A, Kakuyama M, Kato S, Kakimi K, Fukuoka K, Ogiu T, Matsuyama M.
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [Abstract] [Full Text] [Related]

  • 11. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [Abstract] [Full Text] [Related]

  • 12. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D, Casey JW.
    Science; 1986 Mar 21; 231(4744):1437-40. PubMed ID: 3006241
    [Abstract] [Full Text] [Related]

  • 13. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus.
    Siders WM, Halloran PJ, Fenton RG.
    Cancer Gene Ther; 1998 Mar 21; 5(5):281-91. PubMed ID: 9824047
    [Abstract] [Full Text] [Related]

  • 14. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G, Fan H.
    J Virol; 1990 Dec 21; 64(12):6130-40. PubMed ID: 2173784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
    Kung SK, An DS, Chen IS.
    J Virol; 2000 Apr 21; 74(8):3668-81. PubMed ID: 10729143
    [Abstract] [Full Text] [Related]

  • 17. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
    Okuyama T, Huber RM, Bowling W, Pearline R, Kennedy SC, Flye MW, Ponder KP.
    Hum Gene Ther; 1996 Mar 20; 7(5):637-45. PubMed ID: 8845389
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells.
    Siders WM, Halloran PJ, Fenton RG.
    Cancer Res; 1996 Dec 15; 56(24):5638-46. PubMed ID: 8971169
    [Abstract] [Full Text] [Related]

  • 19. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D, Elliott JF, Chang LJ.
    Gene Ther; 1995 Jun 15; 2(4):269-78. PubMed ID: 7552987
    [Abstract] [Full Text] [Related]

  • 20. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors.
    Shi CX, Hitt M, Ng P, Graham FL.
    Hum Gene Ther; 2002 Jan 20; 13(2):211-24. PubMed ID: 11812278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.